Austrian APEPTICO has got Horizon 2020 money for accelerated development and clinical use of Solnatide for the treatment of COVID-19 patients
The European Medicines Agency EMA has backed eight medicines for approval at its virtual March 2020 meeting.
Scandinavian researchers have created a unified, open-source model providing a genome-wide portrait of human disease metabolism.
Paris-based Novacyt SA has signed a global distribution agreement with Bruker Ltd for its COVID-19 diagnostic test.
AC Immune SA has received a milestone payment of CHF10m from Eli Lilly and Company.
Scientists have discussed a link between Covid-19 and sepsis at a virtual symposium at Charité Berlin that might help reduce the burden of end-stage disease.
Evonik Industries has established a new animal-free and fermentation-based industrial-scale recombinant collagen production platform.
Chinese Fosun Pharma Ltd has made the largest investment in a foreign company for a COVID-19 vaccine development: BioNTech’d mRNA vaccine BNT162.
Under its Green Deal, the European Commission has presented a circular (bio)economay action plan that prepares the ground for a sustainable bio-economy.